Cricket Health is a company.
Cricket Health has raised $27.1M across 3 funding rounds.
Key people at Cricket Health.
Cricket Health has raised $27.1M in total across 3 funding rounds.
Cricket Health has raised $27.1M in total across 3 funding rounds.
Cricket Health's investors include Amplify Partners, Battery Ventures, Boldstart Ventures, Bow Capital, BoxGroup, Canaan Partners, Cedar Capital Group, Citi Ventures, City Light Capital, HG Ventures, Hitachi Ventures, IA Ventures.
Cricket Health was a technology-enabled healthcare company specializing in value-based kidney care, focusing on chronic kidney disease (CKD) and end-stage kidney disease (ESKD). It built a platform integrating data analytics, personalized patient education, and multidisciplinary care teams—including nurses, dietitians, social workers, and pharmacists—to identify high-risk patients early, slow disease progression, improve quality of life, and reduce healthcare costs.[1][2][4] Serving patients, health plans, and providers primarily in the U.S., Cricket partnered with insurers and health systems to deliver in-person, remote, and at-home care, including dialysis support and peer resources.[1][2] Following its August 2022 merger into InterWell Health, Cricket's model now scales nationwide, impacting over 270,000 patients under value-based arrangements, with continued momentum shown at events like the 2024 J.P. Morgan Healthcare Conference.[1][5]
Founded in 2015 in San Francisco by co-founder and CEO Arvind Rajan and others, Cricket Health emerged from recognition that kidney care was "broken" due to misaligned incentives pushing patients toward costly in-center dialysis.[2][4] Rajan, drawing from frontline insights, aimed to empower patients with personalized options; the team started by consulting medical professionals on ideal kidney care designs.[4] Early traction included a $2.5 million seed round in 2016 from investors like First Round Capital and NFX Guild, followed by a $24 million Series A in 2018 to expand clinical footprint and tech for care management.[2][3] Pivotal moments: Winning MedCity INVEST’s health IT pitch in 2017 and opening a Boston office to grow operations.[2][6] By 2021, focus shifted to earlier disease stages and accurate risk-stratification, fueling commercial contracts before the 2022 merger with Fresenius Health Partners and InterWell Health, blending Cricket's data innovations with established networks.[1][4][5]
Cricket Health rode the wave of value-based care trends in kidney disease—a costly U.S. chronic condition affecting millions—capitalizing on payer momentum, government incentives, and demand for early intervention amid rising CKD/ESKD prevalence.[1][4][5] Timing was ideal: Pre-merger funding in 2018 aligned with health tech investments; the 2022 InterWell merger amplified scale during a shift to integrated networks, influencing ecosystem by pioneering tech for prevention/screening and medically tailored meals.[1][2][5] It addressed "upside-down incentives" in dialysis-heavy care, pushing personalized models that payers/investors now prioritize, and set precedents for data-driven chronic disease management across healthcare.[2][4]
Cricket Health's innovations endure within InterWell Health, positioning it for expanded early detection and nationwide value-based kidney care amid growing payer adoption and tech integration. Trends like AI-enhanced risk-stratification and preventive nutrition will shape its path, potentially influencing broader chronic care ecosystems by proving scalable, patient-first models reduce costs and improve lives. As InterWell leverages Cricket's legacy, expect deeper physician partnerships and outcomes data to solidify its ecosystem role, evolving from startup disruptor to foundational player in healthier aging populations. This builds on Cricket's original mission: restoring patient control in a broken system.[1][4][5]
Key people at Cricket Health.
Cricket Health has raised $27.1M across 3 funding rounds. Most recently, it raised $24.0M Series A in September 2018.
